Can I read Azacitidine Administration Guidelines on EtoBox?

Azacitidine Administration Guidelines by Gabriel is a document available to read on EtoBox.

What is Azacitidine Administration Guidelines about?

Azacitidine is an option for patients with intermediate-2 or high risk myelodysplastic syndrome, chronic myelomonocytic leukaemia with 10-29% marrow blasts without myeloproliferative disorder, or AML with 20-30% blasts and multilineage dysplasia who are not eligible for stem cell transplantation. It is administered subcutaneously once daily for 5 days every 28 days or on days 1-5 and 8-9. Toxicities include myelosuppression, injection site reactions, ovarian failure, and infertility. Dose reductions or dela

Author

Gabriel

Language

EN